Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INTERPACE BIOSCIENCES, INC. | 871,681 | reported | 05 Mar 2015 | tx 26+1,590,929−69,046 |
| COLLEGIUM PHARMACEUTICAL, INC | 26,758 | reported | 14 May 2026 | tx 4+31,258−4,500 |
| Aquestive Therapeutics, Inc. | 20,000 | reported | 15 Jun 2021 | tx 4+74,050 |
| Alkermes plc. | 18,222 | reported | 21 May 2026 | tx 22+122,812−25,088 |
| Keenova Therapeutics plc | 10,965 | reported | 16 Mar 2016 | tx 7+11,936−1,429 |
| AUXILIUM PHARMACEUTICALS INC | 0 | reported | 29 Jan 2015 | tx 22+72,430−72,430 |
| EyePoint, Inc. | 0 | reported | 06 Jan 2026 | tx 154+8,381,690−2,318,025 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | EXERCISE | Alkermes plc. | 6,142 | — | |
| 21 May 2026 | TAX_WITHHOLDING | Alkermes plc. | 1,475 | 36.95 USD | |
| 20 May 2026 | GRANT_AWARD | Alkermes plc. | 11,538 | 0.00 USD | deriv |
| 20 May 2026 | GRANT_AWARD | Alkermes plc. | 5,409 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | Alkermes plc. | 6,142 | — | deriv |
| 14 May 2026 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 8,741 | 0.00 USD | |
| 13 May 2026 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 4,500 | 35.97 USD | |
| 06 Jan 2026 | EXERCISE | EyePoint, Inc. | 75,133 | 0.00 USD | |
| 06 Jan 2026 | EXERCISE | EyePoint, Inc. | 75,133 | 0.00 USD | deriv |
| 05 Jan 2026 | EXERCISE | EyePoint, Inc. | 12,666 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | EyePoint, Inc. | 40,000 | 0.00 USD | deriv |
| 05 Jan 2026 | EXERCISE | EyePoint, Inc. | 12,666 | 0.00 USD | deriv |
| 04 Dec 2025 | SALE | EyePoint, Inc. | 9,300 | 15.11 USD | |
| 26 Nov 2025 | SALE | EyePoint, Inc. | 200 | 14.95 USD | anomaly |
| 28 Nov 2025 | SALE | EyePoint, Inc. | 500 | 14.95 USD | anomaly |
| 10 Jul 2025 | EXERCISE | EyePoint, Inc. | 11,111 | 0.00 USD | |
| 10 Jul 2025 | EXERCISE | EyePoint, Inc. | 11,111 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 55,000 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 27,270 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 27,270 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 15,278 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 15,278 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 31,165 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 31,165 | 0.00 USD | deriv |
| 02 Jul 2025 | GIFT | EyePoint, Inc. | 55,000 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 16 Aug 2024.